Literature DB >> 27981407

The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis.

Cristina R Bosoi1, Mariana M Oliveira1, Rafael Ochoa-Sanchez1, Mélanie Tremblay1, Gabriella A Ten Have2, Nicolaas E Deutz2, Christopher F Rose1, Chantal Bemeur3,4.   

Abstract

Muscle mass loss and hepatic encephalopathy (complex neuropsychiatric disorder) are serious complications of chronic liver disease (cirrhosis) which impact negatively on clinical outcome and quality of life and increase mortality. Liver disease leads to hyperammonemia and ammonia toxicity is believed to play a major role in the pathogenesis of hepatic encephalopathy. However, the effects of ammonia are not brain-specific and therefore may also affect other organs and tissues including muscle. The precise pathophysiological mechanisms underlying muscle wasting in chronic liver disease remains to be elucidated. In the present study, we characterized body composition as well as muscle protein synthesis in cirrhotic rats with hepatic encephalopathy using the 6-week bile duct ligation (BDL) model which recapitulates the main features of cirrhosis. Compared to sham-operated control animals, BDL rats display significant decreased gain in body weight, altered body composition, decreased gastrocnemius muscle mass and circumference as well as altered muscle morphology. Muscle protein synthesis was also significantly reduced in BDL rats compared to control animals. These findings demonstrate that the 6-week BDL experimental rat is a relevant model to study liver disease-induced muscle mass loss.

Entities:  

Keywords:  Ammonia; Experimental cirrhosis; Hepatic encephalopathy; Muscle mass loss; Protein synthesis

Mesh:

Substances:

Year:  2016        PMID: 27981407     DOI: 10.1007/s11011-016-9937-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  41 in total

1.  Measurement of muscle protein fractional synthesis and breakdown rates from a pulse tracer injection.

Authors:  Xiao-Jun Zhang; David L Chinkes; Robert R Wolfe
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-10       Impact factor: 4.310

Review 2.  Nutrition in end-stage liver disease: principles and practice.

Authors:  Alastair O'Brien; Roger Williams
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

3.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

4.  Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis.

Authors:  Jia Qiu; Cynthia Tsien; Samjhana Thapalaya; Arvind Narayanan; Conrad Chris Weihl; James K Ching; Bijan Eghtesad; Kamini Singh; Xiaoming Fu; George Dubyak; Christine McDonald; Alex Almasan; Stanley L Hazen; Sathyamangla V Naga Prasad; Srinivasan Dasarathy
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-14       Impact factor: 4.310

5.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

6.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

7.  Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme A derivatives.

Authors:  J C Lai; A J Cooper
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

Review 8.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.

Authors:  Gangarao Davuluri; Dawid Krokowski; Bo-Jhih Guan; Avinash Kumar; Samjhana Thapaliya; Dharmvir Singh; Maria Hatzoglou; Srinivasan Dasarathy
Journal:  J Hepatol       Date:  2016-06-16       Impact factor: 25.083

10.  Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure.

Authors:  Chantal Bémeur; Paul Desjardins; Roger F Butterworth
Journal:  J Nutr Metab       Date:  2010-12-22
View more
  6 in total

1.  Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.

Authors:  Milan Holeček; Melita Vodeničarovová
Journal:  Int J Exp Pathol       Date:  2019-01-13       Impact factor: 1.925

2.  Photobiomodulation intervention improves oxidative, inflammatory, and morphological parameters of skeletal muscle in cirrhotic Wistar rats.

Authors:  Diogo Scalon; Jaqueline Nascimento Picada; Jayne Torres de Sousa; Ariane Tainá da Silva; Josieli Raskopf Colares; Norma Anair Possa Marroni
Journal:  Lasers Med Sci       Date:  2021-11-04       Impact factor: 3.161

3.  Sepsis and cirrhosis in growing animals: description of a new experimental model and its pathological and immunological reliability.

Authors:  Pedro Augusto Dantas de Moraes; Ana Cristina Aoun Tannuri; Livio Moreira Rios; Vitor Ribeiro Paes; Josiane de Oliveira Gonçalves; Suellen Serafini; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2020-09-28       Impact factor: 2.365

Review 4.  Preclinical insights into the gut-skeletal muscle axis in chronic gastrointestinal diseases.

Authors:  Luise Ehlers; Karen Bannert; Sarah Rohde; Peggy Berlin; Johannes Reiner; Mats Wiese; Julia Doller; Markus M Lerch; Ali A Aghdassi; Fatuma Meyer; Luzia Valentini; Ottavia Agrifoglio; Cornelia C Metges; Georg Lamprecht; Robert Jaster
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

5.  Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction.

Authors:  Mohammad Mehdi Ommati; Omid Farshad; Hossein Niknahad; Khadijeh Mousavi; Marjan Moein; Negar Azarpira; Hamidreza Mohammadi; Akram Jamshidzadeh; Reza Heidari
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-06-16

6.  The metabolic and molecular mechanisms of hyperammonaemia- and hyperethanolaemia-induced protein catabolism in skeletal muscle cells.

Authors:  Hannah Crossland; Kenneth Smith; Philip J Atherton; Daniel J Wilkinson
Journal:  J Cell Physiol       Date:  2018-08-24       Impact factor: 6.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.